Prognosis evaluation is a clinical study that affects the choice of treatment measures and disease outcomes. With the development of imaging technology, imaging biomarkers have become increasingly important in the assessment of prognosis. As an expert in the field of biomarkers, Creative BioMart Biomarker provides a variety of research and technology outsourcing services related to imaging biomarkers, including prognosis evaluation-related imaging biomarker detection service to help customers advance related prognostic research projects. In addition, we also provide imaging biomarker detection services related to disease risk evaluation, early diagnosis, disease staging and evaluation of tumor efficacy.
Prognosis refers to the prediction of future outcomes or consequences of the disease, and the likelihood of these outcomes. Without any treatment intervention, diseases go through the entire process from occurrence, development to outcome. This is the natural history of the disease, which includes four periods, namely biologic onset stage, subclinical stage, clinical stage and outcome. In the clinical phase of the disease, various medical interventions may be experienced. After the disease occurs, it will have different development trends in different situations, so the possible outcomes of the disease include healing, remission, deterioration, recurrence, disability, complications, and death. The purpose of prognostic research is to predict the probability of a certain disease outcome through meticulous and rigorous scientific research design and data analysis, and to explore many factors that affect the results, including favorable factors and disadvantages. Prognostic factors refer to factors that can affect the outcome of the disease, including the physical condition of patient, disease characteristics, medical conditions, etc. The prognosis of the disease involves three aspects, including the future result of the disease, the probability of a certain result and the time when this result occurs. Disease prognosis research is of great clinical significance. It helps doctors and patients understand the development trend and consequences of the disease, identify the factors that affect the development trend and consequences of the disease, correctly assess the consequences of treatment measures and select treatment options. The ultimate goal of prognosis evaluation is to change the outcome of the disease, make the disease develop in the direction of benefiting the patient, reduce the mortality, disability, recurrence rate, and improve the life quality of the patient. In prognostic studies, imaging biomarkers have been used as a class of non-invasive biomarkers as an adjunct to histopathology. The emergence of various modern imaging technologies has promoted the identification of new prognostic factors based solely on imaging results, and promoted personalized treatment strategies. The reasonable application of imaging biomarkers may have potential to improve the prediction of disease outcomes. Researches on imaging biomarkers have been conducted in diseases such as rectal cancer and kidney transplantation.
Figure 1. Evaluation of nonischemic cardiomyopathy using CMR (Patel, et al. 2017)
Prognosis evaluation-related imaging biomarker detection service is applicable to the research of various diseases such as cancer, sarcoidosis, kidney transplantation, etc.
At Creative BioMart Biomarker, we provide customers with high-quality imaging biomarker detection services related to prognosis evaluation. Customers can discuss with our expert team based on specific research needs or research objects, and we will work out the appropriate experimental plan as soon as possible. Our technical team has extensive experience in the field of imaging biomarkers, and has been strictly controlling every process in the imaging biomarker detection service to ensure that customers are provided with accurate test results. If you are seeking related services, Creative BioMart Biomarker may be your ideal choice, please feel free to contact us for more information.